Phylogeny and phenotypes of clinical and environmental Shiga toxin-producing Escherichia coli O174.

Shiga toxin (Stx)-producing Escherichia coli (STEC) of serogroup O174 are human pathogenic intimin gene (eae)-negative STEC. To facilitate diagnosis and subtyping, we genotypically and phenotypically characterized 25 STEC O174 isolates from humans with different clinical outcomes and from animals and the environment. fliC genotyping resulted in four different genotypes (fliCH2 : n = 5; fliCH8 : n = 8; fliCH21 : n = 11; fliCH46 : n = 1). Twenty-three strains were motile expressing the corresponding H antigen; two non-motile isolates possessed fliCH8 . The stx genotypes and non-stx virulence loci, including toxins, serine-proteases and adhesins correlated well with serotypes but showed no differences with respect to the isolates' origins. Multilocus sequence typing identified seven sequence types that correlated with serotypes. Core gene typing further specified the four serotypes, including a previously unknown O174:H46 combination, and revealed distant relationships of the different serotypes within serogroup O174 and in relation to other haemolytic uremic syndrome (HUS)-associated STEC. Only serotype O174:H21 was associated with HUS. Differences in virulence factors and in the adherence capacity of STEC O174 corroborated this separation into four distinct groups. Our study provides a basis for O174 subtyping, unravels considerable genotypic and phenotypic heterogeneity and sheds light to potential environmental and animal reservoirs.

[1]  Miguel Vicente,et al.  The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak , 2012, EMBO molecular medicine.

[2]  Stefano Morabito,et al.  Multicenter Evaluation of a Sequence-Based Protocol for Subtyping Shiga Toxins and Standardizing Stx Nomenclature , 2012, Journal of Clinical Microbiology.

[3]  Craig S. Wong,et al.  Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  A. Mellmann,et al.  Effects of Antibiotics on Shiga Toxin 2 Production and Bacteriophage Induction by Epidemic Escherichia coli O104:H4 Strain , 2012, Antimicrobial Agents and Chemotherapy.

[5]  M. Heurich,et al.  Detection and characterization of Shiga toxin-producing Escherichia coli in faeces and lymphatic tissue of free-ranging deer , 2012, Epidemiology and Infection.

[6]  L. Beutin,et al.  Outbreak of Shiga toxin-producing Escherichia coli (STEC) O104:H4 infection in Germany causes a paradigm shift with regard to human pathogenicity of STEC strains. , 2012, Journal of food protection.

[7]  Klaus Stark,et al.  Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. , 2011, The New England journal of medicine.

[8]  H. Karch,et al.  No evidence of the Shiga toxin-producing E. coli O104:H4 outbreak strain or enteroaggregative E. coli (EAEC) found in cattle faeces in northern Germany, the hotspot of the 2011 HUS outbreak area , 2011, Gut pathogens.

[9]  A. Mellmann,et al.  Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. , 2011, The Lancet. Infectious diseases.

[10]  J. Rothberg,et al.  Prospective Genomic Characterization of the German Enterohemorrhagic Escherichia coli O104:H4 Outbreak by Rapid Next Generation Sequencing Technology , 2011, PloS one.

[11]  A. Owoade,et al.  Potentially zoonotic shiga toxin-producing Escherichia coli serogroups in the faeces and meat of food-producing animals in Ibadan, Nigeria. , 2010, International journal of food microbiology.

[12]  M. Rivas,et al.  Virulence profile comparison between LEE-negative Shiga toxin-producing Escherichia coli (STEC) strains isolated from cattle and humans. , 2010, Veterinary microbiology.

[13]  V. Gannon,et al.  Verocytotoxin-producing Escherichia coli (VTEC). , 2010, Veterinary microbiology.

[14]  L. Beutin,et al.  Characteristics of shiga toxin-producing Escherichia coli isolated from Swiss raw milk cheese within a 3-year monitoring program. , 2010, Journal of food protection.

[15]  L. Beutin,et al.  Assessment of Shiga Toxin-Producing Escherichia coli Isolates from Wildlife Meat as Potential Pathogens for Humans , 2009, Applied and Environmental Microbiology.

[16]  A. Torres,et al.  Genes Related to Long Polar Fimbriae of Pathogenic Escherichia coli Strains as Reliable Markers To Identify Virulent Isolates , 2009, Journal of Clinical Microbiology.

[17]  A. Mellmann,et al.  Shiga Toxin, Cytolethal Distending Toxin, and Hemolysin Repertoires in Clinical Escherichia coli O91 Isolates , 2009, Journal of Clinical Microbiology.

[18]  P. Fach,et al.  Screening of food raw materials for the presence of Shiga toxin‐producing Escherichia coli O91:H21 , 2009, Letters in applied microbiology.

[19]  M. Karczmarczyk,et al.  Detection of numerous verotoxigenic E. coli serotypes, with multiple antibiotic resistance from cattle faeces and soil. , 2009, Veterinary microbiology.

[20]  A. Mellmann,et al.  Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic Escherichia coli , 2008, Emerging infectious diseases.

[21]  A. Friedrich,et al.  New Immuno-PCR Assay for Detection of Low Concentrations of Shiga Toxin 2 and Its Variants , 2008, Journal of Clinical Microbiology.

[22]  L. Beutin,et al.  Molecular Characterization Reveals Similar Virulence Gene Content in Unrelated Clonal Groups of Escherichia coli of Serogroup O174 (OX3) , 2007, Journal of bacteriology.

[23]  A. Siitonen,et al.  Tracing Shigatoxigenic Escherichia coli O103, O145, and O174 Infections from Farm Residents to Cattle , 2007, Journal of Clinical Microbiology.

[24]  A. Mellmann,et al.  Subtypes of the Plasmid-Encoded Serine Protease EspP in Shiga Toxin-Producing Escherichia coli: Distribution, Secretion, and Proteolytic Activity , 2007, Applied and Environmental Microbiology.

[25]  S. Shackelford,et al.  Microbiological characterization of lamb carcasses at commercial processing plants in the United States. , 2007, Journal of food protection.

[26]  L. Beutin,et al.  Identification of Human-Pathogenic Strains of Shiga Toxin-Producing Escherichia coli from Food by a Combination of Serotyping and Molecular Typing of Shiga Toxin Genes , 2007, Applied and Environmental Microbiology.

[27]  J. Blanco,et al.  Serotypes, virulence genes, and intimin types of Shiga toxin-producing Escherichia coli (STEC) and enteropathogenic E. coli (EPEC) isolated from calves in São Paulo, Brazil. , 2007, International journal of food microbiology.

[28]  A. Mellmann,et al.  Structural and functional differences between disease-associated genes of enterohaemorrhagic Escherichia coli O111. , 2007, International journal of medical microbiology : IJMM.

[29]  L. Beutin,et al.  Identification of Sequence Diversity in the Escherichia coli fliC Genes Encoding Flagellar Types H8 and H40 and Its Use in Typing of Shiga Toxin-Producing E. coli O8, O22, O111, O174, and O179 Strains , 2006, Journal of Clinical Microbiology.

[30]  A. Friedrich,et al.  Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  C. Svanborg,et al.  Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. , 2006, Blood.

[32]  G. Attwood,et al.  Serotypes and analysis of distribution of Shiga toxin-producing Escherichia coli from cattle and sheep in the lower North Island, New Zealand , 2006, New Zealand veterinary journal.

[33]  A. Mellmann,et al.  Chromosomal Dynamism in Progeny of Outbreak-Related Sorbitol-Fermenting Enterohemorrhagic Escherichia coli O157:NM , 2006, Applied and Environmental Microbiology.

[34]  A. Mellmann,et al.  Shiga Toxin 2e-Producing Escherichia coli Isolates from Humans and Pigs Differ in Their Virulence Profiles and Interactions with Intestinal Epithelial Cells , 2005, Applied and Environmental Microbiology.

[35]  H. Karch,et al.  Enterohaemorrhagic Escherichia coli in human medicine. , 2005, International journal of medical microbiology : IJMM.

[36]  A. Mellmann,et al.  Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  P. Tarr,et al.  Shiga-toxin-producing and haemolytic uraemic syndrome , 2005 .

[38]  P. Tarr,et al.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.

[39]  H. Karch,et al.  Phenotypic and Molecular Analysis of Tellurite Resistance among Enterohemorrhagic Escherichia coli O157:H7 and Sorbitol-Fermenting O157:NM Clinical Isolates , 2005, Journal of Clinical Microbiology.

[40]  J. Blanco,et al.  Virulence genes and intimin types of Shiga-toxin-producing Escherichia coli isolated from cattle and beef products in Argentina. , 2004, International microbiology : the official journal of the Spanish Society for Microbiology.

[41]  S. Iyoda,et al.  Distribution of Putative Adhesins in Different Seropathotypes of Shiga Toxin-Producing Escherichia coli , 2004, Journal of Clinical Microbiology.

[42]  A. Mellmann,et al.  Phylogeny, Clinical Associations, and Diagnostic Utility of the Pilin Subunit Gene (sfpA) of Sorbitol-Fermenting, Enterohemorrhagic Escherichia coli O157:H− , 2004, Journal of Clinical Microbiology.

[43]  F. Scheutz,et al.  Designation of O174 and O175 to temporary O groups OX3 and OX7, and six new E. coli O groups that include Verocytotoxin‐producing E. coli (VTEC): O176, O177, O178, O179, O180 and O181 , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[44]  P. Srimanote,et al.  A New Family of Potent AB5 Cytotoxins Produced by Shiga Toxigenic Escherichia coli , 2004, The Journal of experimental medicine.

[45]  H. Karch,et al.  Phenotypic and Genotypic Analyses of Enterohemorrhagic Escherichia coli O145 Strains from Patients in Germany , 2004, Journal of Clinical Microbiology.

[46]  H. Karch,et al.  Characterization of Cytolethal Distending Toxin Genes and Expression in Shiga Toxin-Producing Escherichia coli Strains of Non-O157 Serogroups , 2004, Infection and Immunity.

[47]  A. Torres,et al.  Characterization of the second long polar (LP) fimbriae of Escherichia coli O157:H7 and distribution of LP fimbriae in other pathogenic E. coli strains. , 2004, FEMS microbiology letters.

[48]  F. Gunzer,et al.  Comparison of a Shiga Toxin Enzyme-Linked Immunosorbent Assay and Two Types of PCR for Detection of Shiga Toxin-Producing Escherichia coli in Human Stool Specimens , 2003, Journal of Clinical Microbiology.

[49]  Gilbert S Chen,et al.  Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. , 2003, The Journal of infectious diseases.

[50]  A. Friedrich,et al.  Shiga Toxin 1c-Producing Escherichia coli Strains: Phenotypic and Genetic Characterization and Association with Human Disease , 2003, Journal of Clinical Microbiology.

[51]  J. Blanco,et al.  Serotypes, Virulence Genes, and Intimin Types of Shiga Toxin (Verotoxin)-Producing Escherichia coli Isolates from Healthy Sheep in Spain , 2003, Journal of Clinical Microbiology.

[52]  A. Fruth,et al.  Subtyping of pathogenic Escherichia coli strains using flagellar (H)-antigens: serotyping versus fliC polymorphisms. , 2003, International journal of medical microbiology : IJMM.

[53]  R. Robins-Browne,et al.  Identification of a Novel Fimbrial Gene Cluster Related to Long Polar Fimbriae in Locus of Enterocyte Effacement-Negative Strains of Enterohemorrhagic Escherichia coli , 2002, Infection and Immunity.

[54]  F. Blattner,et al.  Identification and Characterization of lpfABCC′DE, a Fimbrial Operon of Enterohemorrhagic Escherichia coli O157:H7 , 2002, Infection and Immunity.

[55]  N. Perna,et al.  Genomic Variability of O Islands Encoding Tellurite Resistance in Enterohemorrhagic Escherichia coli O157:H7 Isolates , 2002, Journal of bacteriology.

[56]  H. Karch,et al.  Identification, Characterization, and Distribution of a Shiga Toxin 1 Gene Variant (stx1c) in Escherichia coli Strains Isolated from Humans , 2002, Journal of Clinical Microbiology.

[57]  J. Paton,et al.  Direct Detection and Characterization of Shiga Toxigenic Escherichia coli by Multiplex PCR for stx1, stx2, eae, ehxA, and saa , 2002, Journal of Clinical Microbiology.

[58]  H. Karch,et al.  Identification and distribution of the enterohemorrhagic Escherichia coli factor for adherence (efa1) gene in sorbitol-fermenting Escherichia coli O157: H-. , 2002, International journal of medical microbiology : IJMM.

[59]  A. Friedrich,et al.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. , 2002, The Journal of infectious diseases.

[60]  P. Srimanote,et al.  Characterization of Saa, a Novel Autoagglutinating Adhesin Produced by Locus of Enterocyte Effacement-Negative Shiga-ToxigenicEscherichia coli Strains That Are Virulent for Humans , 2001, Infection and Immunity.

[61]  H. Karch,et al.  Identification and Characterization of a Novel Genomic Island Integrated at selC in Locus of Enterocyte Effacement-Negative, Shiga Toxin-Producing Escherichia coli , 2001, Infection and Immunity.

[62]  T. Voss,et al.  The AIDA Autotransporter System Is Associated with F18 and Stx2e in Escherichia coli Isolates from Pigs Diagnosed with Edema Disease and Postweaning Diarrhea , 2001, Clinical Diagnostic Laboratory Immunology.

[63]  F. Grimont,et al.  Identification of Escherichia coli flagellar types by restriction of the amplified fliC gene. , 2000, Research in microbiology.

[64]  Craig S. Wong,et al.  The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. , 2000, The New England journal of medicine.

[65]  T. R. Ward,et al.  Iha: a Novel Escherichia coli O157:H7 Adherence-Conferring Molecule Encoded on a Recently Acquired Chromosomal Island of Conserved Structure , 2000, Infection and Immunity.

[66]  J. Lanser,et al.  Molecular Characterization of a Shiga ToxigenicEscherichia coli O113:H21 Strain Lacking eaeResponsible for a Cluster of Cases of Hemolytic-Uremic Syndrome , 1999, Journal of Clinical Microbiology.

[67]  U. Fagundes-neto,et al.  A Localized Adherence-Like Pattern as a Second Pattern of Adherence of Classic Enteropathogenic Escherichia coli to HEp-2 Cells That Is Associated with Infantile Diarrhea , 1999, Infection and Immunity.

[68]  S. Lauwers,et al.  Identification of New Verocytotoxin Type 2 Variant B-Subunit Genes in Human and Animal Escherichia coliIsolates , 1998, Journal of Clinical Microbiology.

[69]  A. Siitonen,et al.  Shiga toxin-producing Escherichia coli serotype OX3:H21 as a cause of hemolytic-uremic syndrome. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  H. Karch,et al.  EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V , 1997, Molecular microbiology.

[71]  T. Yamamoto,et al.  Detection of the enteroaggregative Escherichia coli heat-stable enterotoxin 1 gene sequences in enterotoxigenic E. coli strains pathogenic for humans , 1996, Infection and immunity.

[72]  L. Beutin,et al.  Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933 , 1995, Infection and immunity.

[73]  Serotype O104H Outbreak of acute gastroenteritis attributable to Escherichia coli serotype O104:H21--Helena, Montana, 1994. , 1995, MMWR. Morbidity and mortality weekly report.

[74]  C. Siddons,et al.  Use of tellurite for the selection of verocytotoxigenic Escherichia coli O157. , 1993, Journal of medical microbiology.

[75]  M. Levine,et al.  Enteroaggregative Escherichia coli elaborate a heat-stable enterotoxin demonstrable in an in vitro rabbit intestinal model. , 1991, The Journal of clinical investigation.